Cold Pain Therapy Comprehensive Study by Type (OTC-Based Products, Prescription-Based Products), Application (Musculoskeletal Disorders, Sport Medicine, Physical Therapy, Post Operative Therapy, Post-Trauma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Players and Region - Global Market Outlook to 2026

Cold Pain Therapy Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 4.5%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Cold Pain Therapy Market Scope
Cold pain therapy, a therapeutic application of cold that includes the usage of cold materials in the treatment of acute soft tissue injuries and to reduce the pain in post-operative condition in orthopaedic surgeries. The surging prevalence of prostate, cervical cancer, skin and other and increasing rate of accidental and sports injuries are the fuelling the growth of the cold pain therapy market across the globe.

According to AMA, the Global Cold Pain Therapy market is expected to see growth rate of 4.5% and may see market size of USD2.4 Billion by 2026.

Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Cold Pain Therapy market throughout the predicted period.

Sanofi (France), DJO Finance (United States), Pfizer (United States), 3M (United States), Hisamitsu Pharmaceutical (Japan), Johnson & Johnson (United States), Medline Industries (United States), Íssur (Iceland), Performance Health (United States), Beiersdorf (Germany) and Rohto Pharmaceutical (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Breg (United States), Romsons Group of Industries (India), Custom Ice (United States) and Unexo Life Sciences (India).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Cold Pain Therapy market by Type (OTC-Based Products and Prescription-Based Products), by Application (Musculoskeletal Disorders, Sport Medicine, Physical Therapy, Post Operative Therapy and Post-Trauma) and Region with country level break-up.

On the basis of geography, the market of Cold Pain Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Market Trend
  • Growing Adoption of Analgesic Patches
  • Increasing Number of Hip and Knee Surgeries Across the Globe

Market Drivers
  • Increasing Incidence of Sports Injuries and Rising Emphasis on Exercise and Gym Activities
  • Growing Need for Safer Pain Management Modalities as Opposed to Oral Drug Therapy
  • Clinical Evidence in Favour of Menthol-Based Topical Analgesics

Opportunities
  • Aging Population Sensitive to Traumatic Injuries
  • Growing Awareness Among Consumers Owing to Promotional Marketing Strategies
  • Growing Use of Cold Pain Therapy Among Middle-Aged Women
  • Increasing Regulatory Barriers for Oral Pain Medications

Restraints
  • High Usage of Low-Priced Analgesic Pills for Immediate Pain Relief
  • Lack of Substantial Clinical Evidence in Favor of Cold Pain Therapy
  • Health Hazards and Discomfort Associated With Cold Pain Therapy Products

Challenges
  • Lack of Reimbursement
  • Availability of Alternative Non-Drug/Device Pain Management Therapies
  • Stringent Regulations on Ammonium Nitrate Usage


Key Target Audience
Cold pain therapy product manufacturers, Healthcare service providers, Distributors and suppliers, Research laboratories and academic institutes, Original equipment manufacturers (OEMs) and Market research companies

Report Objectives / Segmentation Covered

By Type
  • OTC-Based Products
  • Prescription-Based Products
By Application
  • Musculoskeletal Disorders
  • Sport Medicine
  • Physical Therapy
  • Post Operative Therapy
  • Post-Trauma
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Sports Injuries and Rising Emphasis on Exercise and Gym Activities
      • 3.2.2. Growing Need for Safer Pain Management Modalities as Opposed to Oral Drug Therapy
      • 3.2.3. Clinical Evidence in Favour of Menthol-Based Topical Analgesics
    • 3.3. Market Challenges
      • 3.3.1. Lack of Reimbursement
      • 3.3.2. Availability of Alternative Non-Drug/Device Pain Management Therapies
      • 3.3.3. Stringent Regulations on Ammonium Nitrate Usage
    • 3.4. Market Trends
      • 3.4.1. Growing Adoption of Analgesic Patches
      • 3.4.2. Increasing Number of Hip and Knee Surgeries Across the Globe
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cold Pain Therapy, by Type, Application, Distribution Channel and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Cold Pain Therapy (Value)
      • 5.2.1. Global Cold Pain Therapy by: Type (Value)
        • 5.2.1.1. OTC-Based Products
        • 5.2.1.2. Prescription-Based Products
      • 5.2.2. Global Cold Pain Therapy by: Application (Value)
        • 5.2.2.1. Musculoskeletal Disorders
        • 5.2.2.2. Sport Medicine
        • 5.2.2.3. Physical Therapy
        • 5.2.2.4. Post Operative Therapy
        • 5.2.2.5. Post-Trauma
      • 5.2.3. Global Cold Pain Therapy by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Online Pharmacies
      • 5.2.4. Global Cold Pain Therapy Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Cold Pain Therapy (Price)
      • 5.3.1. Global Cold Pain Therapy by: Type (Price)
  • 6. Cold Pain Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sanofi (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. DJO Finance (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pfizer (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. 3M (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Hisamitsu Pharmaceutical (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Johnson & Johnson (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medline Industries (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Íssur (Iceland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Performance Health (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Beiersdorf (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Rohto Pharmaceutical (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Cold Pain Therapy Sale, by Type, Application, Distribution Channel and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Cold Pain Therapy (Value)
      • 7.2.1. Global Cold Pain Therapy by: Type (Value)
        • 7.2.1.1. OTC-Based Products
        • 7.2.1.2. Prescription-Based Products
      • 7.2.2. Global Cold Pain Therapy by: Application (Value)
        • 7.2.2.1. Musculoskeletal Disorders
        • 7.2.2.2. Sport Medicine
        • 7.2.2.3. Physical Therapy
        • 7.2.2.4. Post Operative Therapy
        • 7.2.2.5. Post-Trauma
      • 7.2.3. Global Cold Pain Therapy by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Online Pharmacies
      • 7.2.4. Global Cold Pain Therapy Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Cold Pain Therapy (Price)
      • 7.3.1. Global Cold Pain Therapy by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cold Pain Therapy: by Type(USD Billion)
  • Table 2. Cold Pain Therapy OTC-Based Products , by Region USD Billion (2015-2020)
  • Table 3. Cold Pain Therapy Prescription-Based Products , by Region USD Billion (2015-2020)
  • Table 4. Cold Pain Therapy: by Application(USD Billion)
  • Table 5. Cold Pain Therapy Musculoskeletal Disorders , by Region USD Billion (2015-2020)
  • Table 6. Cold Pain Therapy Sport Medicine , by Region USD Billion (2015-2020)
  • Table 7. Cold Pain Therapy Physical Therapy , by Region USD Billion (2015-2020)
  • Table 8. Cold Pain Therapy Post Operative Therapy , by Region USD Billion (2015-2020)
  • Table 9. Cold Pain Therapy Post-Trauma , by Region USD Billion (2015-2020)
  • Table 10. Cold Pain Therapy: by Distribution Channel(USD Billion)
  • Table 11. Cold Pain Therapy Hospital Pharmacies , by Region USD Billion (2015-2020)
  • Table 12. Cold Pain Therapy Retail Pharmacies , by Region USD Billion (2015-2020)
  • Table 13. Cold Pain Therapy Online Pharmacies , by Region USD Billion (2015-2020)
  • Table 14. South America Cold Pain Therapy, by Country USD Billion (2015-2020)
  • Table 15. South America Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 16. South America Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 17. South America Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 18. Brazil Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 19. Brazil Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 20. Brazil Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 21. Argentina Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 22. Argentina Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 23. Argentina Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 24. Rest of South America Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 25. Rest of South America Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 26. Rest of South America Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 27. Asia Pacific Cold Pain Therapy, by Country USD Billion (2015-2020)
  • Table 28. Asia Pacific Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 29. Asia Pacific Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 30. Asia Pacific Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 31. China Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 32. China Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 33. China Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 34. Japan Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 35. Japan Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 36. Japan Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 37. India Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 38. India Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 39. India Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 40. South Korea Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 41. South Korea Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 42. South Korea Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 43. Taiwan Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 44. Taiwan Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 45. Taiwan Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 46. Australia Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 47. Australia Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 48. Australia Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 49. Rest of Asia-Pacific Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 50. Rest of Asia-Pacific Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 51. Rest of Asia-Pacific Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 52. Europe Cold Pain Therapy, by Country USD Billion (2015-2020)
  • Table 53. Europe Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 54. Europe Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 55. Europe Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 56. Germany Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 57. Germany Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 58. Germany Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 59. France Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 60. France Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 61. France Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 62. Italy Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 63. Italy Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 64. Italy Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 65. United Kingdom Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 66. United Kingdom Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 67. United Kingdom Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 68. Netherlands Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 69. Netherlands Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 70. Netherlands Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 71. Rest of Europe Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 72. Rest of Europe Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 73. Rest of Europe Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 74. MEA Cold Pain Therapy, by Country USD Billion (2015-2020)
  • Table 75. MEA Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 76. MEA Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 77. MEA Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 78. Middle East Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 79. Middle East Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 80. Middle East Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 81. Africa Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 82. Africa Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 83. Africa Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 84. North America Cold Pain Therapy, by Country USD Billion (2015-2020)
  • Table 85. North America Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 86. North America Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 87. North America Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 88. United States Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 89. United States Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 90. United States Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 91. Canada Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 92. Canada Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 93. Canada Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 94. Mexico Cold Pain Therapy, by Type USD Billion (2015-2020)
  • Table 95. Mexico Cold Pain Therapy, by Application USD Billion (2015-2020)
  • Table 96. Mexico Cold Pain Therapy, by Distribution Channel USD Billion (2015-2020)
  • Table 97. Cold Pain Therapy: by Type(USD/Units)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Cold Pain Therapy: by Type(USD Billion)
  • Table 110. Cold Pain Therapy OTC-Based Products , by Region USD Billion (2021-2026)
  • Table 111. Cold Pain Therapy Prescription-Based Products , by Region USD Billion (2021-2026)
  • Table 112. Cold Pain Therapy: by Application(USD Billion)
  • Table 113. Cold Pain Therapy Musculoskeletal Disorders , by Region USD Billion (2021-2026)
  • Table 114. Cold Pain Therapy Sport Medicine , by Region USD Billion (2021-2026)
  • Table 115. Cold Pain Therapy Physical Therapy , by Region USD Billion (2021-2026)
  • Table 116. Cold Pain Therapy Post Operative Therapy , by Region USD Billion (2021-2026)
  • Table 117. Cold Pain Therapy Post-Trauma , by Region USD Billion (2021-2026)
  • Table 118. Cold Pain Therapy: by Distribution Channel(USD Billion)
  • Table 119. Cold Pain Therapy Hospital Pharmacies , by Region USD Billion (2021-2026)
  • Table 120. Cold Pain Therapy Retail Pharmacies , by Region USD Billion (2021-2026)
  • Table 121. Cold Pain Therapy Online Pharmacies , by Region USD Billion (2021-2026)
  • Table 122. South America Cold Pain Therapy, by Country USD Billion (2021-2026)
  • Table 123. South America Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 124. South America Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 125. South America Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 126. Brazil Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 127. Brazil Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 128. Brazil Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 129. Argentina Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 130. Argentina Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 131. Argentina Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 132. Rest of South America Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 133. Rest of South America Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 134. Rest of South America Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 135. Asia Pacific Cold Pain Therapy, by Country USD Billion (2021-2026)
  • Table 136. Asia Pacific Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 137. Asia Pacific Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 138. Asia Pacific Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 139. China Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 140. China Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 141. China Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 142. Japan Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 143. Japan Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 144. Japan Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 145. India Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 146. India Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 147. India Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 148. South Korea Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 149. South Korea Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 150. South Korea Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 151. Taiwan Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 152. Taiwan Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 153. Taiwan Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 154. Australia Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 155. Australia Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 156. Australia Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 157. Rest of Asia-Pacific Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 158. Rest of Asia-Pacific Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 159. Rest of Asia-Pacific Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 160. Europe Cold Pain Therapy, by Country USD Billion (2021-2026)
  • Table 161. Europe Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 162. Europe Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 163. Europe Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 164. Germany Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 165. Germany Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 166. Germany Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 167. France Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 168. France Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 169. France Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 170. Italy Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 171. Italy Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 172. Italy Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 173. United Kingdom Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 174. United Kingdom Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 175. United Kingdom Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 176. Netherlands Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 177. Netherlands Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 178. Netherlands Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 179. Rest of Europe Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 180. Rest of Europe Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 181. Rest of Europe Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 182. MEA Cold Pain Therapy, by Country USD Billion (2021-2026)
  • Table 183. MEA Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 184. MEA Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 185. MEA Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 186. Middle East Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 187. Middle East Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 188. Middle East Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 189. Africa Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 190. Africa Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 191. Africa Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 192. North America Cold Pain Therapy, by Country USD Billion (2021-2026)
  • Table 193. North America Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 194. North America Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 195. North America Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 196. United States Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 197. United States Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 198. United States Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 199. Canada Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 200. Canada Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 201. Canada Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 202. Mexico Cold Pain Therapy, by Type USD Billion (2021-2026)
  • Table 203. Mexico Cold Pain Therapy, by Application USD Billion (2021-2026)
  • Table 204. Mexico Cold Pain Therapy, by Distribution Channel USD Billion (2021-2026)
  • Table 205. Cold Pain Therapy: by Type(USD/Units)
  • Table 206. Research Programs/Design for This Report
  • Table 207. Key Data Information from Secondary Sources
  • Table 208. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cold Pain Therapy: by Type USD Billion (2015-2020)
  • Figure 5. Global Cold Pain Therapy: by Application USD Billion (2015-2020)
  • Figure 6. Global Cold Pain Therapy: by Distribution Channel USD Billion (2015-2020)
  • Figure 7. South America Cold Pain Therapy Share (%), by Country
  • Figure 8. Asia Pacific Cold Pain Therapy Share (%), by Country
  • Figure 9. Europe Cold Pain Therapy Share (%), by Country
  • Figure 10. MEA Cold Pain Therapy Share (%), by Country
  • Figure 11. North America Cold Pain Therapy Share (%), by Country
  • Figure 12. Global Cold Pain Therapy: by Type USD/Units (2015-2020)
  • Figure 13. Global Cold Pain Therapy share by Players 2020 (%)
  • Figure 14. Global Cold Pain Therapy share by Players (Top 3) 2020(%)
  • Figure 15. Global Cold Pain Therapy share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 18. Sanofi (France) Revenue: by Geography 2020
  • Figure 19. DJO Finance (United States) Revenue, Net Income and Gross profit
  • Figure 20. DJO Finance (United States) Revenue: by Geography 2020
  • Figure 21. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 22. Pfizer (United States) Revenue: by Geography 2020
  • Figure 23. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 24. 3M (United States) Revenue: by Geography 2020
  • Figure 25. Hisamitsu Pharmaceutical (Japan) Revenue, Net Income and Gross profit
  • Figure 26. Hisamitsu Pharmaceutical (Japan) Revenue: by Geography 2020
  • Figure 27. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 28. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 29. Medline Industries (United States) Revenue, Net Income and Gross profit
  • Figure 30. Medline Industries (United States) Revenue: by Geography 2020
  • Figure 31. Íssur (Iceland) Revenue, Net Income and Gross profit
  • Figure 32. Íssur (Iceland) Revenue: by Geography 2020
  • Figure 33. Performance Health (United States) Revenue, Net Income and Gross profit
  • Figure 34. Performance Health (United States) Revenue: by Geography 2020
  • Figure 35. Beiersdorf (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Beiersdorf (Germany) Revenue: by Geography 2020
  • Figure 37. Rohto Pharmaceutical (United States) Revenue, Net Income and Gross profit
  • Figure 38. Rohto Pharmaceutical (United States) Revenue: by Geography 2020
  • Figure 39. Global Cold Pain Therapy: by Type USD Billion (2021-2026)
  • Figure 40. Global Cold Pain Therapy: by Application USD Billion (2021-2026)
  • Figure 41. Global Cold Pain Therapy: by Distribution Channel USD Billion (2021-2026)
  • Figure 42. South America Cold Pain Therapy Share (%), by Country
  • Figure 43. Asia Pacific Cold Pain Therapy Share (%), by Country
  • Figure 44. Europe Cold Pain Therapy Share (%), by Country
  • Figure 45. MEA Cold Pain Therapy Share (%), by Country
  • Figure 46. North America Cold Pain Therapy Share (%), by Country
  • Figure 47. Global Cold Pain Therapy: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Sanofi (France)
  • DJO Finance (United States)
  • Pfizer (United States)
  • 3M (United States)
  • Hisamitsu Pharmaceutical (Japan)
  • Johnson & Johnson (United States)
  • Medline Industries (United States)
  • Íssur (Iceland)
  • Performance Health (United States)
  • Beiersdorf (Germany)
  • Rohto Pharmaceutical (United States)
Additional players considered in the study are as follows:
Breg (United States) , Romsons Group of Industries (India) , Custom Ice (United States) , Unexo Life Sciences (India)
Select User Access Type

Key Highlights of Report


Oct 2021 213 Pages 59 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Cold Pain Therapy study can be customized to meet your requirements. The market size breakdown by type [OTC-Based Products and Prescription-Based Products], by end use application [Musculoskeletal Disorders, Sport Medicine, Physical Therapy, Post Operative Therapy and Post-Trauma].
The Cold Pain Therapy Market is gaining popularity and expected to see strong valuation by 2026.
According to AMA, the Global Cold Pain Therapy market is expected to see growth rate of 4.5%.

Know More About Global and Regional Cold Pain Therapy Report?